To accelerate breakthroughs, the Damon Runyon Foundation provides today's best young scientists with funds to pursue innovative cancer research.
September 30, 2010 > New NIH High-Risk Research Awards announced
The intent of the NIH High-Risk Research Awards is to encourage investigators to explore bold ideas that have the potential to catapult fields forward and speed the translation of research into improved health. We congratulate the Damon Runyon scientists who are recipients of these awards.
Transformative R01 Award:
Madhav Dhodapkar, MD (Damon Runyon-Lilly Clinical Investigator ‘02-‘07), Yale Cancer Center, New Haven; Richard A. Flavell, PhD (Former Fellowship Award Committee Member), Yale University School of Medicine, New Haven; X. Sunney Xie, PhD (Current Fellowship Sponsor), Harvard University, Cambridge
Pioneer Award:
Pamela J. Bjorkman, PhD (Former Fellowship Sponsor), California Institute of Technology, Pasadena; Stephen W. Fesik, PhD (Former Innovation Award Committee Member), Vanderbilt University School of Medicine, Nashville; Jun O. Liu, PhD (Damon Runyon Fellow ‘91-‘93), Johns Hopkins University School of Medicine, Baltimore